Peak Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.02M Sell
2,612
-630
-19% -$743K 1.3% 23
2026
Q2
$3.89M Buy
+3,242
New +$3.31M 1.61% 13
2024
Q3
– Sell
-3,684
Closed -$3.34M – 86
2024
Q2
$3.34M Buy
3,684
+34
+0.9% +$27.2K 1.91% 11
2024
Q1
$2.84M Sell
3,650
-354
-9% -$252K 1.73% 25
2023
Q4
$2.33M Buy
+4,004
New +$2.34M 1.56% 30

Other funds holding LLY

Peak Financial Advisors's LLY Position: Q3 2026 in Review

Peak Financial Advisors reduced its Eli Lilly (LLY) stake by 19% in Q3 2026, selling an estimated $743K and leaving 2,612 shares worth $3.02M. The position accounts for 1.3% of the portfolio, ranked #23.

Peak Financial Advisors first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.89M in Q2 2026. 4,590 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Peak Financial Advisors held 2,612 shares of Eli Lilly worth $3.02M as of Q3 2026.
  • Peak Financial Advisors sold 630 Eli Lilly shares in Q3 2026, an estimated $743K.
  • Eli Lilly made up 1.3% of Peak Financial Advisors's portfolio in Q3 2026, its #23 holding.
  • Peak Financial Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
  • Peak Financial Advisors's Eli Lilly position peaked at $3.89M in Q2 2026.
  • 4,590 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Peak Financial Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.